Frank Mullery
Chief Executive Officer | President | Chief Commercial Officer | Chief Financial Officer | Senior Executive, Pharmaceutical and Biotechnology
- Role
- Chief Executive Officer of Harrow\'s Imprimisrx Division at Harrow
- Location
- Philadelphia, PA, US
- LinkedIn followers
- 500 followers
About Frank Mullery
A Senior Executive with 20 years of experience, primarily in the healthcare and pharmaceutical sectors, with a reputation of success in identifying and executing on unique business opportunities. Previously, I held the role of President of Mylan Institutional where I established Mylan as a key player in the Injectable Market by growing revenues over 20% in 2018 to $1B. Launched Mylan\'s first Biosimilar (Fulphila) in the US, established key partnerships with GPO\'s/IDN\'s/ and wholesale partners, and launched over 20 injectable products last year.Following my tenure at Mylan I joined STI Pharma, where I held the role of President, CFO, and CCO from 2019 through 2021. I was responsible for all the operations of the company including Commercial, Scientific Affairs, Manufacturing, Supply Chain, and Business Development. Provide the vision and strategy for the company translated into a 5-year Strategic Plan. This included establishing STI Pharma’s injectable business, turning around the company, launching 5 products, and leading a sale process partnering with large investment bank resulting in 5 definitive offers to acquire the business.Most recently at Sintetica I, was solely responsible for building a US subsidiary from concept to full commercialization including the successful launch of first 5 productsI am a proven strategic thinker and problem solver who enjoys competing in the marketplace each day, taking on business challenges and working with teams to identify areas of opportunity. I am in a relentless pursuit to get better each day and believe in order to build something special it takes commitment day in and day out.In my experience at Mylan for over 7 years, I served the company in several capacities of increasing responsibility. Prior to my role as President, I served as Chief Financial Officer of North America where I successfully lead the company\'s largest region. I began my career at Mylan as CFO of Mylan Pharmaceuticals Inc, the company\'s flagship generics division in the U.S. focused on oral solid dose products.I earned my Executive MBA from Villanova University and bachelors degree in Accounting from King\'s College.
Experience
Chief Executive Officer of Harrow\'s Imprimisrx Division
Oct 2025 — Present · Philadelphia, PA, US
Education
Villanova University
Executive MBA
2009 — 2011
King's College
Bachelor of Science (BS), Accounting
1994 — 1998
Skills
- Process Improvement
- Pharmaceutical Industry
- Business Process Improvement
- Business Intelligence
- Management
- Financial Reporting
- Strategy
- Mergers
- Forecasting
- Strategic Planning
- Biotechnology
- Business Analysis
- Analytics
- Sarbanes-Oxley Act
- Financial Analysis
- Budgeting
- Cross-Functional Team Leadership
- Managed Care
- Budgets
- Finance
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.